Basilea Looks To Progress Cancer Pipeline As It Expands Zevtera Use
Ceftobiprole Approved In China
Switzerland’s Basilea Pharmaceutica is progressing its lead oncology candidates and a second late-stage US clinical trial of ceftobiprole in difficult-to-treat infections.
